| Sonya Willard, | |
|
13900 Hull Street Rd, Midlothian, VA 23112-2004 | |
| (804) 639-8788 | |
| Not Available |
| Full Name | Sonya Willard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 13900 Hull Street Rd, Midlothian, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033612049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2203000636 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sonya Willard, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: () - | Sonya Willard, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: (804) 639-8788 |
News Archive
Case Western Reserve University School of Medicine and Athersys, Inc. announced a joint scientific study on spinal cord injury will be published today in the January issue of The Journal of Neuroscience.
Once again, AvMed Health Plans has received an Excellent Accreditation status from the National Committee for Quality Assurance (NCQA) for both its commercial and Medicare products, a distinction shared only by a select group of health plans in the country.
Most young women already know that tanning is dangerous and sunbathe anyway, so a campaign informing them of the risk should take into account their potential resistance to the message, according to a new study.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, presented clinical data and analysis from its Phase 2a clinical trial of LX4211 for patients with type 2 diabetes mellitus at ENDO 2010 today. The results reported today included newly-obtained data showing a trend of increased total GLP-1 in both LX4211 treatment arms relative to placebo as measured in a post-trial analysis of blood samples.
In this post in USAID's "IMPACTblog," guest blogger Joanna Breitstein, director of communications for the TB Alliance, describes an event organized by the Critical Paths to TB Drug Regimens that took place on Monday, "heralding the launch of a new clinical trial that tests tuberculosis drugs in combination."
› Verified 8 days ago
Miss Kathryn Easley, M.S., CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Cir, Suite 108, Midlothian, VA 23114 Phone: 800-969-9265 Fax: 804-482-2647 | |
Hayley Wenner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13900 Hull Street Rd, Midlothian, VA 23112 Phone: 804-639-8900 | |
Paige Parker, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14366 Sommerville Ct, Midlothian, VA 23113 Phone: 804-601-6010 Fax: 804-285-0292 | |
Karen Sue Ford, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13714 Nashua Ter, Midlothian, VA 23112 Phone: 804-683-8470 | |
Molly Shearer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13900 Hull Street Rd, Midlothian, VA 23112 Phone: 804-639-8788 | |
Jennie Watson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13900 Hull Street Rd, Midlothian, VA 23112 Phone: 804-639-8788 |